位置:首页 > 蛋白库 > VKOR_SYNJB
VKOR_SYNJB
ID   VKOR_SYNJB              Reviewed;         283 AA.
AC   Q2JJF6;
DT   11-JUN-2014, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 1.
DT   03-AUG-2022, entry version 87.
DE   RecName: Full=Vitamin K epoxide reductase homolog;
DE            Short=VKOR;
DE            EC=1.17.4.-;
GN   OrderedLocusNames=CYB_2278;
OS   Synechococcus sp. (strain JA-2-3B'a(2-13)) (Cyanobacteria bacterium
OS   Yellowstone B-Prime).
OC   Bacteria; Cyanobacteria; Synechococcales; Synechococcaceae; Synechococcus;
OC   unclassified Synechococcus.
OX   NCBI_TaxID=321332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JA-2-3B'a(2-13);
RX   PubMed=18059494; DOI=10.1038/ismej.2007.46;
RA   Bhaya D., Grossman A.R., Steunou A.-S., Khuri N., Cohan F.M., Hamamura N.,
RA   Melendrez M.C., Bateson M.M., Ward D.M., Heidelberg J.F.;
RT   "Population level functional diversity in a microbial community revealed by
RT   comparative genomic and metagenomic analyses.";
RL   ISME J. 1:703-713(2007).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.66 ANGSTROMS) OF MUTANT SER-56 IN COMPLEX WITH
RP   UBIQUINONE, SUBCELLULAR LOCATION, TOPOLOGY, DISULFIDE BOND, FUNCTION,
RP   MUTAGENESIS OF CYS-50; CYS-56; CYS-130; CYS-133; CYS-209 AND CYS-212,
RP   ACTIVITY REGULATION, REDOX-ACTIVE SITE, AND REGION.
RX   PubMed=20110994; DOI=10.1038/nature08720;
RA   Li W., Schulman S., Dutton R.J., Boyd D., Beckwith J., Rapoport T.A.;
RT   "Structure of a bacterial homologue of vitamin K epoxide reductase.";
RL   Nature 463:507-512(2010).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.79 ANGSTROMS) OF 186-283 OF MUTANTS ALA-50 AND
RP   ALA-212 IN COMPLEX WITH UBIQUINONE, FUNCTION, SUBCELLULAR LOCATION,
RP   TOPOLOGY, MUTAGENESIS OF LYS-41; CYS-50; LEU-60; CYS-130 AND CYS-212,
RP   REDOX-ACTIVE SITE, SITE, AND THIOREDOXIN-LIKE REGION.
RX   PubMed=24477003; DOI=10.1038/ncomms4110;
RA   Liu S., Cheng W., Fowle Grider R., Shen G., Li W.;
RT   "Structures of an intramembrane vitamin K epoxide reductase homolog reveal
RT   control mechanisms for electron transfer.";
RL   Nat. Commun. 5:3110-3110(2014).
CC   -!- FUNCTION: Thiol-disulfide oxidoreductase that catalyzes vitamin K-
CC       dependent disulfide bond formation in periplasmic target proteins.
CC       {ECO:0000269|PubMed:20110994, ECO:0000269|PubMed:24477003}.
CC   -!- ACTIVITY REGULATION: Inhibited by ferulenol.
CC       {ECO:0000269|PubMed:20110994}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:20110994,
CC       ECO:0000269|PubMed:24477003}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:20110994, ECO:0000269|PubMed:24477003}.
CC   -!- DOMAIN: Cysteine residues from the thioredoxin-like domain participate
CC       in a series of disulfide-exchange reactions that regenerate the redox-
CC       active cysteine residues in the transmembrane domain.
CC   -!- SIMILARITY: Belongs to the VKOR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000240; ABD03218.1; -; Genomic_DNA.
DR   RefSeq; WP_011433847.1; NC_007776.1.
DR   PDB; 3KP8; X-ray; 1.66 A; A=186-283.
DR   PDB; 3KP9; X-ray; 3.60 A; A=1-283.
DR   PDB; 4NV2; X-ray; 3.61 A; A=1-283.
DR   PDB; 4NV5; X-ray; 2.79 A; A/B=1-283.
DR   PDB; 4NV6; X-ray; 4.19 A; A=1-283.
DR   PDBsum; 3KP8; -.
DR   PDBsum; 3KP9; -.
DR   PDBsum; 4NV2; -.
DR   PDBsum; 4NV5; -.
DR   PDBsum; 4NV6; -.
DR   AlphaFoldDB; Q2JJF6; -.
DR   SMR; Q2JJF6; -.
DR   STRING; 321332.CYB_2278; -.
DR   KEGG; cyb:CYB_2278; -.
DR   eggNOG; COG4243; Bacteria.
DR   HOGENOM; CLU_047345_0_0_3; -.
DR   OMA; WCPHCHE; -.
DR   OrthoDB; 1187526at2; -.
DR   BRENDA; 1.17.4.4; 15616.
DR   EvolutionaryTrace; Q2JJF6; -.
DR   Proteomes; UP000001938; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0048038; F:quinone binding; IEA:UniProtKB-KW.
DR   CDD; cd12916; VKOR_1; 1.
DR   Gene3D; 1.20.1440.130; -; 1.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR012932; VKOR.
DR   InterPro; IPR044698; VKOR/LTO1.
DR   InterPro; IPR038354; VKOR_sf.
DR   Pfam; PF07884; VKOR; 1.
DR   SMART; SM00756; VKc; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; Membrane; Oxidoreductase; Quinone;
KW   Redox-active center; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..283
FT                   /note="Vitamin K epoxide reductase homolog"
FT                   /id="PRO_0000429265"
FT   TOPO_DOM        1..20
FT                   /note="Cytoplasmic"
FT   TRANSMEM        21..41
FT                   /note="Helical"
FT   TOPO_DOM        42..66
FT                   /note="Periplasmic"
FT   TRANSMEM        67..87
FT                   /note="Helical"
FT   TOPO_DOM        88..102
FT                   /note="Cytoplasmic"
FT   TRANSMEM        103..123
FT                   /note="Helical"
FT   TOPO_DOM        124..128
FT                   /note="Periplasmic"
FT   TRANSMEM        129..149
FT                   /note="Helical"
FT   TOPO_DOM        150..158
FT                   /note="Cytoplasmic"
FT   TRANSMEM        159..179
FT                   /note="Helical"
FT   TOPO_DOM        180..283
FT                   /note="Periplasmic"
FT   REGION          186..283
FT                   /note="Thioredoxin-like domain"
FT   BINDING         59..65
FT                   /ligand="a quinone"
FT                   /ligand_id="ChEBI:CHEBI:132124"
FT   BINDING         111..122
FT                   /ligand="a quinone"
FT                   /ligand_id="ChEBI:CHEBI:132124"
FT   SITE            50
FT                   /note="Important for the reduction of the redox-active Cys-
FT                   130 and Cys-133"
FT   SITE            56
FT                   /note="Important for the reduction of the redox-active Cys-
FT                   130 and Cys-133"
FT   SITE            209
FT                   /note="Important for the reduction of the redox-active Cys-
FT                   130 and Cys-133"
FT   SITE            212
FT                   /note="Important for the reduction of the redox-active Cys-
FT                   130 and Cys-133"
FT   DISULFID        50..56
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:20110994"
FT   DISULFID        130..133
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:20110994"
FT   DISULFID        209..212
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:20110994"
FT   DISULFID        231..244
FT                   /evidence="ECO:0000269|PubMed:20110994"
FT   MUTAGEN         41
FT                   /note="K->A: Reduces enzyme activity by about 40% with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:24477003"
FT   MUTAGEN         41
FT                   /note="K->E: Reduces enzyme activity by about 20% with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:24477003"
FT   MUTAGEN         41
FT                   /note="K->R: Minor effect on enzyme activity with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:24477003"
FT   MUTAGEN         41
FT                   /note="K->S: Reduces enzyme activity by about 75% with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:24477003"
FT   MUTAGEN         50
FT                   /note="C->A: Abolishes enzyme activity, but not with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:20110994,
FT                   ECO:0000269|PubMed:24477003"
FT   MUTAGEN         56
FT                   /note="C->A: Abolishes enzyme activity, but not with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:20110994"
FT   MUTAGEN         60
FT                   /note="L->A,G: Reduces enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:24477003"
FT   MUTAGEN         130
FT                   /note="C->A,S: Abolishes enzyme activity, also with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:20110994,
FT                   ECO:0000269|PubMed:24477003"
FT   MUTAGEN         133
FT                   /note="C->A: Abolishes enzyme activity, also with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:20110994"
FT   MUTAGEN         209
FT                   /note="C->A: Abolishes enzyme activity, but not with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:20110994"
FT   MUTAGEN         212
FT                   /note="C->A: Abolishes enzyme activity, but not with
FT                   dithiothreitol as in vitro reductant."
FT                   /evidence="ECO:0000269|PubMed:20110994,
FT                   ECO:0000269|PubMed:24477003"
FT   HELIX           21..42
FT                   /evidence="ECO:0007829|PDB:4NV5"
FT   HELIX           56..61
FT                   /evidence="ECO:0007829|PDB:4NV5"
FT   STRAND          65..67
FT                   /evidence="ECO:0007829|PDB:4NV5"
FT   HELIX           72..88
FT                   /evidence="ECO:0007829|PDB:4NV5"
FT   HELIX           96..124
FT                   /evidence="ECO:0007829|PDB:4NV5"
FT   HELIX           131..148
FT                   /evidence="ECO:0007829|PDB:4NV5"
FT   STRAND          149..151
FT                   /evidence="ECO:0007829|PDB:4NV5"
FT   HELIX           157..181
FT                   /evidence="ECO:0007829|PDB:4NV5"
FT   HELIX           187..199
FT                   /evidence="ECO:0007829|PDB:3KP8"
FT   STRAND          202..205
FT                   /evidence="ECO:0007829|PDB:3KP8"
FT   HELIX           210..219
FT                   /evidence="ECO:0007829|PDB:3KP8"
FT   HELIX           220..225
FT                   /evidence="ECO:0007829|PDB:3KP8"
FT   STRAND          228..231
FT                   /evidence="ECO:0007829|PDB:3KP8"
FT   HELIX           242..246
FT                   /evidence="ECO:0007829|PDB:3KP8"
FT   STRAND          251..257
FT                   /evidence="ECO:0007829|PDB:3KP8"
FT   STRAND          260..264
FT                   /evidence="ECO:0007829|PDB:3KP8"
FT   HELIX           268..275
FT                   /evidence="ECO:0007829|PDB:3KP8"
SQ   SEQUENCE   283 AA;  30593 MW;  615561731469DF16 CRC64;
     MASYLKLKAQ EETWLQRHSR LILAILAGLG SLLTAYLTYT KLTEQPAAFC TGDGGCDLVL
     SSRWAEFLGI PTAAVGLLGF LGVLALAVLP DGLPLVKRWR WPALFGLVSA MTAFEMYMLY
     LMVAVLRQFC MYCTTAIILV AGLGLVTVLG HRWLDGGKLA FSYILVAFLT LVTTIGVYAN
     QVPPPSPLAV GLAAHLRQIG GTMYGAYWCP HCQDQKELFG AAFDQVPYVE CSPNGPGTPQ
     AQECTEAGIT SYPTWIINGR TYTGVRSLEA LAVASGYPLE EGR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024